A detailed history of Seascape Capital Management transactions in Zoetis Inc. stock. As of the latest transaction made, Seascape Capital Management holds 3,870 shares of ZTS stock, worth $677,095. This represents 0.24% of its overall portfolio holdings.

Number of Shares
3,870
Previous 3,874 0.1%
Holding current value
$677,095
Previous $765,000 14.38%
% of portfolio
0.24%
Previous 0.32%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$165.67 - $199.94 $662 - $799
-4 Reduced 0.1%
3,870 $655,000
Q4 2023

Jan 29, 2024

BUY
$151.44 - $200.09 $14,538 - $19,208
96 Added 2.54%
3,874 $765,000
Q3 2023

Nov 09, 2023

SELL
$167.14 - $192.77 $1,002 - $1,156
-6 Reduced 0.16%
3,778 $657,000
Q2 2023

Aug 04, 2023

BUY
$160.94 - $186.23 $482 - $558
3 Added 0.08%
3,784 $652,000
Q1 2023

May 01, 2023

SELL
$145.48 - $175.02 $21,240 - $25,552
-146 Reduced 3.72%
3,781 $629,000
Q4 2022

Jan 31, 2023

BUY
$131.14 - $157.47 $4,196 - $5,039
32 Added 0.82%
3,927 $576,000
Q3 2022

Nov 08, 2022

BUY
$148.29 - $182.55 $7,859 - $9,675
53 Added 1.38%
3,895 $578,000
Q2 2022

Aug 09, 2022

SELL
$155.97 - $200.09 $19,964 - $25,611
-128 Reduced 3.22%
3,842 $660,000
Q1 2022

May 09, 2022

BUY
$181.39 - $234.03 $10,520 - $13,573
58 Added 1.48%
3,970 $749,000
Q4 2021

Jan 27, 2022

BUY
$193.69 - $247.03 $1,743 - $2,223
9 Added 0.23%
3,912 $955,000
Q3 2021

Nov 05, 2021

BUY
$189.29 - $209.69 $165,439 - $183,269
874 Added 28.85%
3,903 $758,000
Q2 2021

Aug 04, 2021

SELL
$155.9 - $187.99 $66,725 - $80,459
-428 Reduced 12.38%
3,029 $477,000
Q2 2021

Aug 04, 2021

BUY
$155.9 - $187.99 $66,725 - $80,459
428 Added 14.13%
3,457 $644,000
Q1 2021

Apr 29, 2021

BUY
$144.0 - $169.39 $117,504 - $138,222
816 Added 36.87%
3,029 $477,000
Q4 2020

Jan 28, 2021

BUY
$157.07 - $174.35 $347,595 - $385,836
2,213 New
2,213 $366,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Seascape Capital Management Portfolio

Follow Seascape Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seascape Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Seascape Capital Management with notifications on news.